The mice are probably relieved a bit anyway.
Love to see the data as the announcement is a bit vague and short of any detail.
I am surprised that CimetrA has not gone through human trials - it has been around for a while, and I thought it has been sold on the market. Next step FDA approval sounds a bit funny in that case.
Ann: Completion of CimetrA Efficacy Pre-clinical Trial, page-3
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
0.005(2.00%) |
Mkt cap ! $12.34M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 25.5¢ | 24.0¢ | $137.1K | 549.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2200 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 100 | 1 |
View Market Depth
| Last trade - 16.10pm 20/08/2024 (20 minute delay) ? |
| RGT (ASX) Chart |